KAS Legal Team Secures $292.5 Million Victory Against Natera in High-Stakes Biotech Patent Dispute
Wilmington, Delaware – In a landmark legal battle that pitted two major players in the medical diagnostics sector against each other, KAS, a legal team representing Guardant Health, secured a stunning $292.5 million jury verdict against Natera Inc. The verdict, delivered after rigorous deliberations, marks a significant turn in the ongoing tensions revolving around patent infringements within the industry. Guardant Health, renowned for its ground-breaking contributions to cancer diagnostics, accused Natera Inc. of infringing on its patented technology, which plays a crucial role in non-invasive cancer tests. These tests are instrumental in detecting early signs … Read more